Ling Xu

Peripheral blood markers predict prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy

In recent years, immunotherapy has significantly reshaped the pattern of non-small cell lung cancer (NSCLC) treatment. However, the issue of how to pinpoint potential responsive populations more accurately warrants immediate and focused attention. This study mainly explored the c...